MedPath

Comparison of remimazolam and propofol on emergence time in patients who undergo awake craniotomy: a randomized comparative study

Not Applicable
Recruiting
Conditions
brain tumor
Registration Number
JPRN-UMIN000041353
Lead Sponsor
Sapporo Medical University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
126
Inclusion Criteria

Not provided

Exclusion Criteria

Patients diagnosed as severe cognitive dysfunction in preoperative period Patients who have allergy for propofol, remimazolam and flumazenil Patients who have severe hepatic dysfunction and/or renal dysfunction Patients determined as inappropriate to include by researcher of this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath